Eric Schmidt - Mar 23, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Chief Financial Officer
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact for Eric Schmidt
Stock symbol
ALLO
Transactions as of
Mar 23, 2022
Transactions value $
$0
Form type
4
Date filed
3/25/2022, 05:49 PM
Previous filing
Mar 17, 2022
Next filing
Jun 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Award $0 +237K +236.07% $0.00 338K Mar 23, 2022 Direct
holding ALLO Common Stock 1.15M Mar 23, 2022 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLO Stock Option (Right to Buy) Award $0 +369K $0.00 369K Mar 23, 2022 Common Stock 369K $9.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter
F2 The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.